Horn T - Search Results

1

NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.

Shulman HM, Cardona DM, Greenson JK, Hingorani S, Horn T, Huber E, Kreft A, Longerich T, Morton T, Myerson D, Prieto VG, Rosenberg A, Treister N, Washington K, Ziemer M, Pavletic SZ, Lee SJ, Flowers ME, Schultz KR, Jagasia M, Martin PJ, Vogelsang GB, Kleiner DE. Shulman HM, et al. Among authors: horn t. Biol Blood Marrow Transplant. 2015 Apr;21(4):589-603. doi: 10.1016/j.bbmt.2014.12.031. Epub 2015 Jan 29. Biol Blood Marrow Transplant. 2015. PMID: 25639770 Free PMC article.

2

Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA).

Vogelsang GB, Wolff D, Altomonte V, Farmer E, Morison WL, Corio R, Horn T. Vogelsang GB, et al. Among authors: horn t. Bone Marrow Transplant. 1996 Jun;17(6):1061-7. Bone Marrow Transplant. 1996. PMID: 8807115

3

Clinical, laboratory, and histopathologic indicators of the development of progressive acute graft-versus-host disease.

Darmstadt GL, Donnenberg AD, Vogelsang GB, Farmer ER, Horn TD. Darmstadt GL, et al. Among authors: horn td. J Invest Dermatol. 1992 Oct;99(4):397-402. doi: 10.1111/1523-1747.ep12616112. J Invest Dermatol. 1992. PMID: 1401996 Free article.

4

Cutaneous graft-versus-host reaction lacks evidence of cutaneous cytomegalovirus by the immunoperoxidase technique.

Horn TD, Farmer ER, Vogelsang GB, Wingard JR, Santos GW. Horn TD, et al. J Invest Dermatol. 1989 Jul;93(1):92-5. doi: 10.1111/1523-1747.ep12277363. J Invest Dermatol. 1989. PMID: 2545790 Free article.

5

Reappraisal of histologic features of the acute cutaneous graft-versus-host reaction based on an allogeneic rodent model.

Horn TD, Bauer DJ, Vogelsang GB, Hess AD. Horn TD, et al. J Invest Dermatol. 1994 Aug;103(2):206-10. doi: 10.1111/1523-1747.ep12392774. J Invest Dermatol. 1994. PMID: 8040611 Free article.

6

Lichen planus-like histopathologic characteristics in the cutaneous graft-vs-host reaction. Prognostic significance independent of time course after allogeneic bone marrow transplantation.

Horn TD, Zahurak ML, Atkins D, Solomon AR, Vogelsang GB. Horn TD, et al. Arch Dermatol. 1997 Aug;133(8):961-5. Arch Dermatol. 1997. PMID: 9267240

7

Etretinate therapy for refractory sclerodermatous chronic graft-versus-host disease.

Marcellus DC, Altomonte VL, Farmer ER, Horn TD, Freemer CS, Grant J, Vogelsang GB. Marcellus DC, et al. Among authors: horn td. Blood. 1999 Jan 1;93(1):66-70. Blood. 1999. PMID: 9864147 Free article.

8

Immune modulation in autologous bone marrow transplantation: cyclosporine and gamma-interferon trial.

Vogelsang G, Bitton R, Piantadosi S, Altomonte V, Horn T, Jones R, Miller C, Marcellus D, Abrams R, Hess A. Vogelsang G, et al. Among authors: horn t. Bone Marrow Transplant. 1999 Sep;24(6):637-40. doi: 10.1038/sj.bmt.1701942. Bone Marrow Transplant. 1999. PMID: 10490729 Clinical Trial.

9

Oral PUVA and topical steroids for treatment of oral manifestations of chronic graft-vs.-host disease.

Wolff D, Anders V, Corio R, Horn T, Morison WL, Farmer E, Vogelsang GB. Wolff D, et al. Among authors: horn t. Photodermatol Photoimmunol Photomed. 2004 Aug;20(4):184-90. doi: 10.1111/j.1600-0781.2004.00102.x. Photodermatol Photoimmunol Photomed. 2004. PMID: 15238096

10

Erythroderma after autologous bone marrow transplantation modified by administration of cyclosporine and interferon gamma for breast cancer.

Horn TD, Altomonte V, Vogelsang G, Kennedy MJ. Horn TD, et al. J Am Acad Dermatol. 1996 Mar;34(3):413-7. doi: 10.1016/s0190-9622(96)90431-4. J Am Acad Dermatol. 1996. PMID: 8609251 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

774 results

Search Page